More than 16 years of Commercial and Scientific experience in Biopharmaceutical

The president and founder of ProPharmance, LLC, Dr. Animesh Poddar has more than 20 years of biopharmaceutical industry experience in various areas of strategic analytics. During his long career Dr. Poddar held several strategic and analytics positions with Roche, GlaxoSmithKline (GSK)and most recently AstraZeneca.
Sales Operations: field experiments design and analyses, targeting, alignment, incentive compensation, reporting, sales force structure and size
Commercial Analytics: marketing mix modeling, promotional strategy & optimization, promotional effectiveness & ROI, regional strategic analyses
BD&L: A direct and hands-on involvement in forecasting, sales & marketing costs estimation, commercial evaluation, decision tree risk and financial evaluation of opportunities and deal structure development (complex forecasting and financial modeling)
A key role in signing several deals worth more than $3.5B in total .
• Acquisition of Ardea BioSciences
• Acquisition of Omthera Pharmaceuticals
• Out-licensing of Nexium OTC to Pfizer (global)
• Out-licensing of Forxiga to Ono (Japan)
• In-licensing of WEE1 inhibitor from Merck
• In-licensing of Fentanyl nasal spray from Archimedes (Australia)
• A multi-asset co-development and co-promotion deal with Amgen
• Deals on Several early stage assets and platforms
• Currently: Scouting, Forecasting, Evaluating, Financial Modeling for various clients
Dr. Poddar received his PhD in Pharmacology from the University of Georgia followed by an MBA from Bowling Green State University. After finishing his BS in Pharmacy from Jadavpur University, India he worked as a sales representative for Winthrop Pharmaceuticals.

Work Terms

Hourly consulting or project rates